Haack-Sørensen Mandana, Follin Bjarke, Juhl Morten, Brorsen Sonja K, Søndergaard Rebekka H, Kastrup Jens, Ekblond Annette
Cardiology Stem Cell Centre, The Heart Centre, Rigshospitalet University of Copenhagen, Juliane Maries Vej 20, Dept. 9302, 2100, Copenhagen, Denmark.
J Transl Med. 2016 Nov 16;14(1):319. doi: 10.1186/s12967-016-1080-9.
Adipose derived stromal cells (ASCs) are a rich and convenient source of cells for clinical regenerative therapeutic approaches. However, applications of ASCs often require cell expansion to reach the needed dose. In this study, cultivation of ASCs from stromal vascular fraction (SVF) over two passages in the automated and functionally closed Quantum Cell Expansion System (Quantum system) is compared with traditional manual cultivation.
Stromal vascular fraction was isolated from abdominal fat, suspended in α-MEM supplemented with 10% Fetal Bovine Serum and seeded into either T75 flasks or a Quantum system that had been coated with cryoprecipitate. The cultivation of ASCs from SVF was performed in 3 ways: flask to flask; flask to Quantum system; and Quantum system to Quantum system. In all cases, quality controls were conducted for sterility, mycoplasmas, and endotoxins, in addition to the assessment of cell counts, viability, immunophenotype, and differentiation potential.
The viability of ASCs passage 0 (P0) and P1 was above 96%, regardless of cultivation in flasks or Quantum system. Expression of surface markers and differentiation potential was consistent with ISCT/IFATS standards for the ASC phenotype. Sterility, mycoplasma, and endotoxin tests were consistently negative. An average of 8.0 × 10 SVF cells loaded into a Quantum system yielded 8.96 × 10 ASCs P0, while 4.5 × 10 SVF cells seeded per T75 flask yielded an average of 2.37 × 10 ASCs-less than the number of SVF cells seeded. ASCs P1 expanded in the Quantum system demonstrated a population doubling (PD) around 2.2 regardless of whether P0 was previously cultured in flasks or Quantum, while ASCs P1 in flasks only reached a PD of 1.0.
Manufacturing of ASCs in a Quantum system enhances ASC expansion rate and yield significantly relative to manual processing in T-flasks, while maintaining the purity and quality essential to safe and robust cell production. Notably, the use of the Quantum system entails significantly reduced working hours and thereby costs.
脂肪来源的间充质干细胞(ASC)是临床再生治疗方法中丰富且便捷的细胞来源。然而,ASC的应用通常需要细胞扩增以达到所需剂量。在本研究中,将在自动化且功能封闭的量子细胞扩增系统(量子系统)中从基质血管成分(SVF)培养ASC两代与传统手动培养进行比较。
从腹部脂肪中分离出基质血管成分,悬浮于补充有10%胎牛血清的α-MEM中,并接种到T75培养瓶或已用冷沉淀包被的量子系统中。从SVF培养ASC有3种方式:培养瓶到培养瓶;培养瓶到量子系统;量子系统到量子系统。在所有情况下,除了评估细胞计数、活力、免疫表型和分化潜能外,还进行了无菌、支原体和内毒素的质量控制。
无论在培养瓶还是量子系统中培养,第0代(P0)和第1代(P1)ASC的活力均高于96%。表面标志物的表达和分化潜能符合ASC表型的国际细胞治疗协会/国际脂肪组织治疗与科学协会(ISCT/IFATS)标准。无菌、支原体和内毒素检测结果始终为阴性。加载到量子系统中的平均8.0×10个SVF细胞产生了8.96×10个P0代ASC,而每个T75培养瓶接种4.5×10个SVF细胞平均产生2.37×10个ASC,少于接种的SVF细胞数量。无论P0代之前是在培养瓶还是量子系统中培养,在量子系统中扩增的P1代ASC的群体倍增数(PD)约为2.2,而培养瓶中的P1代ASC仅达到1.0的PD。
与在T型培养瓶中手动处理相比,在量子系统中制造ASC可显著提高ASC的扩增率和产量,同时保持安全且高效的细胞生产所必需的纯度和质量。值得注意的是,使用量子系统可显著减少工作时间,从而降低成本。